Jackson Grant Investment Advisers’s Chemours CC Stock Holding History

Jackson Grant Investment Advisers’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-246	Closed	-$6K	–	222
2019 Q2	$6K	Hold	246	–	–	﹤0.01%	213
2019 Q1	$9K	Hold	246	–	–	0.01%	209
2018 Q4	$7K	Buy	246 +3	+1%	+$95	﹤0.01%	205
2018 Q3	$10K	Buy	243 +1	+0.4%	+$44	0.01%	191
2018 Q2	$11K	Buy	242 +1	+0.4%	+$50	0.01%	199
2018 Q1	$12K	Buy	241 +1	+0.4%	+$50	0.01%	191
2017 Q4	$12K	Hold	240	–	–	0.01%	191
2017 Q3	$12K	Buy	+240	New	+$11.3K	0.01%	192

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jackson Grant Investment Advisers's CC Position: Q3 2019 in Review

Jackson Grant Investment Advisers sold out of Chemours (CC) in Q3 2019, closing a stake of 246 shares — an estimated $6K sold.

Jackson Grant Investment Advisers first reported a position in CC in Q3 2017 and held it in 8 quarters. The position peaked at $12K in Q1 2018. 418 funds tracked by Wall St. Rank hold CC as of Q3 2019.

Jackson Grant Investment Advisers reported no remaining Chemours position as of Q3 2019 after selling out during the quarter.
Jackson Grant Investment Advisers sold 246 Chemours shares in Q3 2019, an estimated $6K.
Jackson Grant Investment Advisers first reported a position in Chemours in Q3 2017 and held it in 8 quarters.
Jackson Grant Investment Advisers's Chemours position peaked at $12K in Q1 2018.
418 funds tracked by Wall St. Rank held Chemours as of Q3 2019.

Based on Jackson Grant Investment Advisers's 13F filing for Q3 2019, filed 20 Nov 2019.